EP2753322
DOSAGE REGIMEN OF N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.9.2012EP published:
3.8.2016EP application number:
12769146.7
EPO information:
European Patent Register
Max expiry date:
6.9.2032
Title:
DOSAGE REGIMEN OF N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE
Timeline
Today
7.9.2012EP application
3.8.2016EP Publication
Owner
Name:
Pharmacyclics, Inc.Address:
995 East Arques Avenue, 94085, Sunnyvale, CA, US
Inventor
Name:
KLOOS, IoanaAddress:
Rueil Malmaison, FR
Name:
ROBERT, RenataAddress:
Suresnes, FR
Name:
JACQUET-BESCOND, AnneAddress:
Le Plessis Robinson, FR
Name:
DEPIL, StéphaneAddress:
Issy les Moulineaux, FR
Name:
CHENEL, MaryloreAddress:
Paris, FR
Name:
FOULIARD, SylvainAddress:
Paris, FR
Name:
BALASUBRAMANIAN, SriramAddress:
San Carlos, California, US
Priority
Number:
1102727Date:
8.9.2011Country:
FR
Number:
201161573585 PDate:
8.9.2011Country:
US
Classification
Categories:
A61K 31/138, A61K 31/343, A61K 31/704, A61K 33/24, A61P 35/00